News

B-Cell Lymphoma Pipeline Outlook Report 2025: Key 295+ Companies and Breakthrough Therapies Shaping the Future Landscape
In August 2025, Hoffmann-La Roche announced a study is to compare the efficacy and safety of glofitamab in combination with ...